• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较伴有或不伴有骨转移的乳腺癌患者的总氨基末端肽和 I 型前胶原氨基端前肽检测。

Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases.

机构信息

Institute of Diagnostics, Department of Clinical Chemistry, PL 5000, FI-90014, University of Oulu, Oulu.

出版信息

Ann Clin Biochem. 2011 Sep;48(Pt 5):447-51. doi: 10.1258/acb.2011.011040. Epub 2011 Jul 6.

DOI:10.1258/acb.2011.011040
PMID:21733929
Abstract

BACKGROUND

Aminoterminal propeptide of type I procollagen (PINP) reflects bone formation. Two different antigens exist in human serum: intact PINP and a monomeric form. The intact PINP assay measures trimeric form and the total assay measures both forms. The structure and origin of the monomeric form is still unclear.

METHODS

Automated intact and total PINP assays were compared in breast cancer patients with (n = 60) or without bone metastases (n = 226). In addition, cross-linked carboxyterminal telopeptide of type I collagen (ICTP) was measured from the same patients and compared with the concentration of PINP monomer (difference between intact and total PINP). Monomeric PINP was purified from human ascitic fluid and characterized by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).

RESULTS

The correlations were good (r > 0.948) between intact PINP and total P1NP in all patient groups. The correlation between the monomeric form and ICTP was lower in patients without bone metastases (r = 0.507) than in patients with bone metastases (r = 0.894). This indicates that the monomeric form reflects the degradation of type I collagen because bone metastases are osteolytic in nature. After several steps in the purification of the monomer form there was a single peak. Only the single band was visible in the SDS-PAGE gel. The alpha1-chain of intact PINP consists of 161 amino acids with a molecular weight of 14224.02. The purified monomer peptide in MALDI-TOF MS was smaller, 10576.41, and most likely cleaved after the arginine residue (amino acid number 120) with a trypsin-like protease.

CONCLUSIONS

Intact and total PINP assays give similar results in many conditions, but there are differences, for example in breast carcinoma, which should be recognized.

摘要

背景

I 型前胶原氨基端前肽(PINP)反映了骨形成。人血清中存在两种不同的抗原:完整的 PINP 和单体形式。完整的 PINP 测定法测定三聚体形式,总测定法测定两种形式。单体形式的结构和来源尚不清楚。

方法

比较了 60 例乳腺癌伴骨转移患者(n=60)和 226 例无骨转移患者(n=226)的全自动完整和总 PINP 测定值。此外,还从同一患者中测量了 I 型胶原交联羧基末端肽(ICTP)并与 PINP 单体浓度(完整和总 PINP 之间的差异)进行比较。从人腹水纯化单体 PINP,并用十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)和基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF MS)进行鉴定。

结果

所有患者组中,完整 PINP 与总 PINP 的相关性均良好(r>0.948)。无骨转移患者(r=0.507)单体形式与 ICTP 的相关性低于骨转移患者(r=0.894),表明单体形式反映了 I 型胶原的降解,因为骨转移本质上是溶骨性的。单体形式经过几个纯化步骤后,出现了一个单一的峰。SDS-PAGE 凝胶中仅可见单一条带。完整 PINP 的α1 链由 161 个氨基酸组成,分子量为 14224.02。MALDI-TOF MS 中纯化的单体肽较小,为 10576.41,很可能在胰蛋白酶样蛋白酶作用下,在精氨酸残基(120 号氨基酸)后被切割。

结论

在许多情况下,完整和总 PINP 测定法的结果相似,但也存在差异,例如在乳腺癌中,应加以识别。

相似文献

1
Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases.比较伴有或不伴有骨转移的乳腺癌患者的总氨基末端肽和 I 型前胶原氨基端前肽检测。
Ann Clin Biochem. 2011 Sep;48(Pt 5):447-51. doi: 10.1258/acb.2011.011040. Epub 2011 Jul 6.
2
Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide.I 型前胶原 N 端前肽总量和完整测定值的差异反映了 pN 胶原的降解,而不是完整前肽的变性。
Ann Clin Biochem. 2010 Jan;47(Pt 1):67-71. doi: 10.1258/acb.2009.009110. Epub 2009 Nov 25.
3
The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.I型胶原的氨基端前肽(PINP)是骨转移乳腺癌中骨转换和转移扩散程度的临床有效指标。
Anticancer Res. 2007 Jul-Aug;27(4A):1853-62.
4
Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.血清I型胶原羧基末端肽(ICTP)以及I型前胶原羧基末端和氨基末端前肽(PICP、PINP)的浓度作为乳腺癌转移性骨病的标志物。
Anticancer Res. 1996 Jul-Aug;16(4B):2289-93.
5
[Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].[I型胶原交联N-端肽(NTx)作为前列腺癌患者骨转移标志物的临床应用——与血清PICP、PINP和ICTP的比较]
Hinyokika Kiyo. 2000 Dec;46(12):869-72.
6
Type I collagen metabolites as tumor markers in patients with lung carcinoma.I型胶原代谢产物作为肺癌患者的肿瘤标志物
Cancer. 1999 May 1;85(9):1951-7.
7
Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum.血清Ⅰ型前胶原氨基端前肽(PINP)的测定。
Clin Biochem. 2012 Aug;45(12):920-7. doi: 10.1016/j.clinbiochem.2012.03.023. Epub 2012 Mar 27.
8
Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer.血清中的术后Ⅰ型前胶原氨基端前肽(PINP)反映了淋巴结阳性乳腺癌的转移潜能及较差的生存率。
Anticancer Res. 2001 Jul-Aug;21(4B):2873-6.
9
PINP as serum marker of metastatic spread to the bone in breast cancer patients.PINP作为乳腺癌患者骨转移扩散的血清标志物。
Anticancer Res. 2005 May-Jun;25(3A):1491-9.
10
Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer.唑来膦酸治疗转移性乳腺癌时骨标志物测量用于监测反应的有效性。
Oncol Rep. 2013 Jul;30(1):441-7. doi: 10.3892/or.2013.2409. Epub 2013 Apr 22.

引用本文的文献

1
A practical use of bone turnover markers in management of patients with skeletal fragility.骨转换标志物在骨骼脆弱患者管理中的实际应用。
Endocrine. 2025 May 29. doi: 10.1007/s12020-025-04275-y.
2
Latest Advances in Structural Insights and Quantification Techniques for Type I Collagen Biomarkers: A path toward standardization?I型胶原蛋白生物标志物的结构见解与定量技术的最新进展:迈向标准化之路?
Biomark Insights. 2025 May 24;20:11772719251336274. doi: 10.1177/11772719251336274. eCollection 2025.
3
Puerarin alleviates osteoporosis in rats by targeting the JAK2/STAT3 signaling pathway.
葛根素通过靶向 JAK2/STAT3 信号通路缓解大鼠骨质疏松症。
Biomol Biomed. 2024 Oct 17;24(6):1651-1661. doi: 10.17305/bb.2024.10500.
4
Bone Metastasis of Breast Cancer: Molecular Mechanisms and Therapeutic Strategies.乳腺癌骨转移:分子机制与治疗策略
Cancers (Basel). 2022 Nov 22;14(23):5727. doi: 10.3390/cancers14235727.
5
Association of bone-related biomarkers with femoral neck bone strength.骨相关生物标志物与股骨颈骨强度的关系。
BMC Musculoskelet Disord. 2022 May 21;23(1):482. doi: 10.1186/s12891-022-05427-1.
6
Influence of hyperbaric oxygen therapy on bone metabolism in patients with neoplasm.高压氧疗法对肿瘤患者骨代谢的影响
Rep Pract Oncol Radiother. 2021 Apr 14;26(2):163-169. doi: 10.5603/RPOR.a2021.0022. eCollection 2021.
7
Harmonised Australian Reference Intervals for Serum PINP and CTX in Adults.成人血清PINP和CTX的澳大利亚统一参考区间
Clin Biochem Rev. 2014 Nov;35(4):237-42.
8
Markedly elevated serum total N-terminal propeptide of type I collagen is a novel marker for the diagnosis and follow up of patients with POEMS syndrome.
Haematologica. 2014 Jun;99(6):e78-80. doi: 10.3324/haematol.2013.102962. Epub 2014 Mar 21.
9
Type I Collagen Synthesis Marker Procollagen I N-Terminal Peptide (PINP) in Prostate Cancer Patients Undergoing Intermittent Androgen Suppression.Ⅰ型胶原合成标志物前胶原 I N 端肽(PINP)在接受间歇性雄激素抑制治疗的前列腺癌患者中的变化。
Cancers (Basel). 2011 Sep 15;3(3):3601-9. doi: 10.3390/cancers3033601.
10
Human bone marrow mesenchymal stem cells induce collagen production and tongue cancer invasion.人骨髓间充质干细胞诱导胶原产生和舌癌侵袭。
PLoS One. 2013 Oct 21;8(10):e77692. doi: 10.1371/journal.pone.0077692. eCollection 2013.